SonoThera
Developing ultrasound-mediated nonviral genetic medicines.
About
Technology stack
detected 2026-06-10“SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.
What does SonoThera do?
SonoThera is a biotechnology company developing a proprietary, non-invasive approach to genetic medicine using ultrasound-mediated delivery (UMD). This technology enables broad, highly targeted biodistribution of diverse genetic payloads, including DNA and RNA constructs of unlimited size, in a redosable and cost-effective manner. SonoThera aims to bring this safe and well-tolerated genetic medicine to patients.
How much funding has SonoThera raised?
SonoThera has raised a total of $125M in funding. The most recent round on record is Series B.
Where is SonoThera headquartered?
SonoThera is headquartered in San Francisco, California, USA.
When was SonoThera founded?
SonoThera was founded in 2019.
What industry does SonoThera operate in?
SonoThera operates in Biotechnology, Healthcare, Gene Therapy, Medical Devices, Biotech, MedTech.
How many employees does SonoThera have?
SonoThera has approximately 54 people on record.